The patent covers the process and preparation of Tapentadol for the treatment of moderate to severe-acute pain Ness Ziona, Israel, June 18, 2013 —- Mapi Pharma Ltd. (Mapi), developer of complex bulk Active Pharmaceutical Ingredients (APIs), generic and...
The patent covers a long acting depot formulation that enables monthly rather than daily treatment regimens for MS patients Ness Ziona, Israel, May 6, 2013 —- Mapi Pharma Ltd. (Mapi), developer of complex bulk Active Pharmaceutical Ingredients (APIs), generic...
The patent covers intermediate compounds and processes for the preparation of Fingolimod Ness Ziona, Israel, February 18, 2014 —- Mapi Pharma Ltd. (“Mapi” or the “Company”), a developer of high-barrier to entry and high value-added generic drugs that include... 